Jeffrey S. Williams
Private Equity Investor bei Summit Life Sciences Management LLC
Profil
Jeffrey S.
Williams was the founder of e-Nicotine Technology, Inc. (founded in 2012), where he held the title of President, Chief Executive Officer & Director.
He is currently working as a General Partner at Summit Life Sciences Management LLC since 2009.
In his former positions, he served as a Director at NanoSurface Technologies LLC, Director at Summit Access, Inc. (from 2010 to 2016), Vice President-Corporate Development at Faraday Pharmaceuticals, Inc. (Washington) (from 2001 to 2004), Senior Vice President-Operations & Manufacturing at Alexza Pharmaceuticals, Inc. (from 2004 to 2007), Chief Business Officer at Concert Pharmaceuticals, Inc. (in 2007), and Vice President-Corporate Development & Strategy at EmerGen, Inc. (in 2001).
He also served as President at Alexza Singapore Pte Ltd.
(from 2008 to 2009).
Mr. Williams obtained a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brigham Young University.
Aktive Positionen von Jeffrey S. Williams
| Unternehmen | Position | Beginn |
|---|---|---|
Summit Life Sciences Management LLC
 Summit Life Sciences Management LLC Investment ManagersFinance SUMMIT LIFE SCIENCE Management LLC (Summit Life Sciences) is a venture capital firm founded in 2012. The firm is headquartered in Draper, Utah. | Private Equity Investor | 01.10.2009 |
Ehemalige bekannte Positionen von Jeffrey S. Williams
| Unternehmen | Position | Ende |
|---|---|---|
Summit Access LLC
 Summit Access LLC Medical/Nursing ServicesHealth Services Summit Access LLC designs and manufactures medical device to create streamlined solutions for use in interventional radiology, interventional cardiology, and vascular surgery procedures. It distributes MicroTaper safety introducer set. The company was founded in 2010 and is headquartered in Englewood, CO. | Direktor/Vorstandsmitglied | 01.02.2016 |
| Alexza Singapore Pte Ltd. | Präsident | 01.03.2009 |
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2008 |
Faraday Pharmaceuticals, Inc. (Washington)
 Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.02.2004 |
| EmerGen, Inc. | Corporate Officer/Principal | 01.08.2001 |
Ausbildung von Jeffrey S. Williams
| Massachusetts Institute of Technology | Graduate Degree |
| Brigham Young University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
| Alexza Singapore Pte Ltd. | |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
Faraday Pharmaceuticals, Inc. (Washington)
Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Retail Trade |
| EmerGen, Inc. | |
NanoSurface Technologies LLC
 NanoSurface Technologies LLC Medical SpecialtiesHealth Technology NanoSurface Technologies LLC designs and manufactures medical devices. The company is headquartered in Maple Grove, MN. | Health Technology |
Summit Access LLC
Summit Access LLC Medical/Nursing ServicesHealth Services Summit Access LLC designs and manufactures medical device to create streamlined solutions for use in interventional radiology, interventional cardiology, and vascular surgery procedures. It distributes MicroTaper safety introducer set. The company was founded in 2010 and is headquartered in Englewood, CO. | Health Services |
e-Nicotine Technology, Inc.
 e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Health Technology |
Summit Life Sciences Management LLC
Summit Life Sciences Management LLC Investment ManagersFinance SUMMIT LIFE SCIENCE Management LLC (Summit Life Sciences) is a venture capital firm founded in 2012. The firm is headquartered in Draper, Utah. | Finance |
